Article
Effects of cardiomyopeptidin on myocardial injury in ICU patients: a prospective randomized controlled pilot study
2026-06-28
Abstract excerpt
<title>Abstract</title> <p> Background Cardiomyopeptidin (CMP) is a peptide-based drug derived from the ventricular muscle of healthy young pigs. As a peptide mixture, it has been suggested to target myocardial cells, potentially aiding in the repair of damaged myocardium, reducing myocardial oxygen consumption, and improving cardiac function, as indicated by preliminary studies. This study aims to investigate...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 13c4dfdc-025a-545e-97ba-bcbd5051038a
- DOI
- 10.21203/rs.3.rs-9912976/v1
